PR Newswire

Digital therapeutics startup Respiree™ announces incorporation in US with residency at JLABS @ San Francisco

Respiree announced today that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @ South San Francisco from February 12, 2024. By expanding footprint within the US, Respiree aims to deepen its relationships and networks within the pharma and life science sector. Respiree was formerly a company at JLABS in Singapore.

Digital therapeutics startup Respiree™ announces incorporation in US with residency at JLABS @ San Francisco Read More